News from ani pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 02, 2015, 09:36 ET

ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration (FDA)...

May 15, 2015, 08:00 ET

ANI Pharmaceuticals Presents at the UBS Global Healthcare Conference

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on May 20, 2015 at the UBS Global Healthcare Conference at the Sheraton New York Times Square...

May 13, 2015, 08:00 ET

ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has acquired the approved new drug application ("NDA") for a testosterone...

May 05, 2015, 08:00 ET

ANI Pharmaceuticals Reports First Quarter 2015 Financial Results

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2015 and reaffirmed its...

Apr 28, 2015, 08:00 ET

ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2015 financial results on Tuesday, May...

Apr 07, 2015, 16:30 ET

ANI Pharmaceuticals Presents At 14th Annual Needham Healthcare Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on April 14, 2015 at Needham & Company's 14th Annual Healthcare Conference at the...

Mar 31, 2015, 08:00 ET

ANI Pharmaceuticals Announces the Launch of Propafenone Tablets

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets,...

Mar 10, 2015, 08:00 ET

ANI Pharmaceuticals Announces the Launch of Etodolac 200mg Capsules

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Etodolac 200mg oral capsules, indicated for use in the management of...

Mar 05, 2015, 08:30 ET

ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has acquired the approved abbreviated new drug application ("ANDA")...

Mar 04, 2015, 08:30 ET

ANI Pharmaceuticals To Present At 27th Annual ROTH Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that it will present at the 27th Annual ROTH Conference at the Ritz-Carlton at Laguna...

Feb 19, 2015, 08:30 ET

ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and twelve months ended December 31, 2014 and...

Feb 12, 2015, 08:30 ET

ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2014 Financial Results

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2014 financial...

Feb 03, 2015, 08:30 ET

ANI Pharmaceuticals Announces Appointment of Dr. David Sullivan to VP of Quality Operations

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the promotion of David J. Sullivan, Ph.D. to the position of Vice President,...

Jan 30, 2015, 08:30 ET

ANI Pharmaceuticals Announces the Launch of Etodolac 300mg Capsules

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Etodolac 300mg oral capsules, indicated for use in the...

Dec 11, 2014, 08:30 ET

ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present today at the Oppenheimer & Co. 25th Annual Healthcare Conference at the Crowne Plaza...

Dec 10, 2014, 12:33 ET

ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the "Company") today announced that it has closed an underwritten public offering of its 3.00%...

Dec 05, 2014, 08:23 ET

ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the "Company") today announced the pricing of an underwritten public offering of $125,000,000 aggregate...

Dec 04, 2014, 09:00 ET

ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the "Company") today announced that it is offering $100,000,000 aggregate principal amount of...

Nov 06, 2014, 08:30 ET

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the...

Nov 03, 2014, 08:30 ET

ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and...